Skip to main content

Table 4 Clinical characteristics and distribution of WHO grade in three different ependymoma groups defined by TNC expression and chromosome 1q25 status

From: Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma

 

Gender (m:f ratio)

Median age years (range)

WHO grade (II/III)

TNC pos/1q25 gain

(group 1)

1:1

4.2

(1.4–17.3)

0/10

TNC pos/no 1q25 gain

(group 2)

1.4:1

2.1

(0.9–11.3)

8/21

TNC neg/no 1q25 gain

(group 3)

4:1

9.9

(3.6–20)

5/0

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us